Cite
HARVARD Citation
Schwarz, T. et al. (n.d.). 1239. Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated. Open forum infectious diseases. pp. S638-S639. [Online].